Millions battle persistent skin flare-ups, facing daily discomfort and frustration. Discover the latest insights into treatment and prevention.
Scalp psoriasis can cause crusty patches or scales on the surface of the head. Find details about medicated shampoos, ...
One poster will share pooled INTEGUMENT data of ZORYVE® (roflumilast) cream 0.15% in atopic dermatitis (AD) in patients with prior inadequate ...
Face mapping is an ancient practice that links specific locations of acne on the face to health issues affecting specific ...
Clinical phenotypes of atopic dermatitis can vary greatly based on skin color and can make atopic dermatitis difficult to diagnose.
Driven by the viral #SephoraKids social media trend, girls using damaging anti-aging products. A pediatrician explains the risks and offers tips to counter them.
Arcutis Biotherapeutics is advancing in alopecia areata and atopic dermatitis with ZORYVE. Learn why ARQT stock offers growth ...
Topical roflumilast, 0.05%, is under consideration for treating mild to moderate atopic dermatitis in children aged 2-5 years ...
This once-daily topical treatment is the latest phosphodiesterase-4 (PDE4) inhibitor designed for mild to moderate atopic ...
The Company submitted an sNDA for ZORYVE foam for scalp and body psoriasis to the FDA based on the positive results from the pivotal ARRECTOR Phase 3 trial and a Phase 2b trial, which was accepted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results